Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats
Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats
复制标题
DOI:
10.1016/j.ajodo.2009.05.028
复制
发表时间:
2011-03-01
影响因子:
3
通讯作者:
Maki, Kenshi
中科院分区:
文献类型:
--
作者:
Fujita, Yuko;Watanabe, Koji;Maki, Kenshi
Introduction: This study was performed to estimate the effects of risedronate on mandibular bone density, bone structure, and bone metabolism in established glucocorticoid-induced osteoporosis in growing rats. Methods: The rats were given oral risedronate at 0, 0.5, or 1.0 mg per kilogram per day for 4 weeks after the administration of oral prednisolone at 30 mg per kilogram per 2 days for 6 weeks. Trabecular and cortical bone masses were analyzed by using peripheral quantitative computed tomography, and bone structure and bone formation were measured by using static and dynamic histomorphometry. Results: In trabecular bone, risedronate improved the prednisolone-induced decreases in bone cross-sectional area and bone mineral content. Risedronate increased bone density and also formed dense bone microarchitecture by reducing the bone turnover rate. In cortical bone, risedronate improved the prednisolone-induced decreases in bone cross-sectional area and bone mineral content without affecting bone density by increasing the mineralizing surface. Conclusions: Risedronate improved prednisolone-induced retardation of trabecular and cortical bone growth, but the bone turnover in these 2 sites was regulated differently in the growing rat mandibles. (Am J Orthod Dentofacial Orthop 2011;139:e267-e277)